Safety Profile, Efficacy, and Biodistribution of a Bicistronic High-Capacity Adenovirus Vector Encoding a Combined Immunostimulation and Cytotoxic Gene Therapy as a Prelude to a Phase I Clinical Trial for Glioblastoma

Lignende værker

• Study of the Efficacy, Biodistribution, and Safety Profile of Therapeutic Gutless Adenovirus Vectors as a Prelude to a Phase I Clinical Trial for Glioblastoma
  af: Muhammad, AKMG, et al.
  Udgivet: (2010)
• Safety Profile of Gutless Adenovirus Vectors Delivered into the Normal Brain Parenchyma: Implications for a Glioma Phase 1 Clinical Trial
  af: Ghulam Muhammad, A.K.M., et al.
  Udgivet: (2012)
• Marmosets as a preclinical model for testing “off-label” use of doxycycline to turn on Flt3L expression from high-capacity adenovirus vectors
  af: VanderVeen, Nathan, et al.
  Udgivet: (2014)
• Development of approaches for studying the biodistribution of a bicistronic therapeutic plasmid construct in the mouse body
  af: S. S. Dzhauari, et al.
  Udgivet: (2022-07-01)
• Effectiveness and Preclinical Safety Profile of Doxycycline to Be Used “Off-Label” to Induce Therapeutic Transgene Expression in a Phase I Clinical Trial for Glioma
  af: VanderVeen, Nathan, et al.
  Udgivet: (2013)